Patents by Inventor Frank Dahlke

Frank Dahlke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
    Publication number: 20220016076
    Abstract: The present invention relates to siponimod (BAF312) for use in the treatment of an autoimmune disease, wherein an immediate release dosage form is administered once daily to a patient as maintenance regimen and wherein the patient has experienced a specific titration regimen with siponimod beforehand.
    Type: Application
    Filed: June 2, 2020
    Publication date: January 20, 2022
    Inventors: Eric Legangneux, Erik Wallström, Philippe Michel Rene Bouillot, Emeric Reynaud, Frank Dahlke
  • Dosing Regimen of Siponimod
    Publication number: 20200316021
    Abstract: The present disclosure relates to a novel dosing regimen for the administration of siponimod or pharmaceutically acceptable co-crystals or salts thereof, in the treatment of stroke, in particular ischemic stroke, e.g. acute ischemic stroke.
    Type: Application
    Filed: September 27, 2018
    Publication date: October 8, 2020
    Inventors: Jang-Ho Cha, Frank Dahlke, Anne Gardin, Eric Legangneux, Carl Joseph Malanga, III, Kasra Shakeri-Nejad, Erik Wallstrom, Christian Wolf
  • Dosing Regimen of Siponimod
    Publication number: 20200306222
    Abstract: The present disclosure relates to a novel dosing regimen for the administration of siponimod or pharmaceutically acceptable co-crystals or salts thereof, in the treatment of stroke, in particular intracerebral hemorrhage (ICH).
    Type: Application
    Filed: September 27, 2018
    Publication date: October 1, 2020
    Inventors: Jang-Ho Cha, Frank Dahlke, Anne Gardin, Eric Legangneux, Carl Joseph Malanga, III, Kasra Shakeri-Nejad, Erik Wallstrom, Christian Wolf
  • SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
    Publication number: 20190054065
    Abstract: The present invention relates to siponimod (BAF312) for use in the treatment of an autoimmune disease, wherein an immediate release dosage form is administered once daily to a patient as maintenance regimen and wherein the patient has experienced a specific titration regimen with siponimod beforehand.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 21, 2019
    Inventors: Eric Legangneux, Erik Wallström, Philippe Michel Rene Bouillot, Emeric Reynaud, Frank Dahlke
  • SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
    Publication number: 20170027907
    Abstract: The present invention relates to siponimod (BAF312) for use in the treatment of an autoimmune disease, wherein an immediate release dosage form is administered once daily to a patient as maintenance regimen and wherein the patient has experienced a specific titration regimen with siponimod beforehand.
    Type: Application
    Filed: April 8, 2015
    Publication date: February 2, 2017
    Inventors: Eric Legangneux, Erik Wallström, Philippe Michel Rene Bouillot, Emeric Reynaud, Frank Dahlke
  • Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
    Patent number: 6894038
    Abstract: The invention relates to the use of esters of estriol, for example, an estriol 3,17-dipropionate or an estriol 3,17-dihexanoate, for the treatment of autoimmune diseases, such as multiple sclerosis (MS).
    Type: Grant
    Filed: February 27, 2003
    Date of Patent: May 17, 2005
    Assignee: Schering Aktiengesellschaft
    Inventors: Walter Elger, Sybille Beier, Harald Von Keyserlingk, Frank Dahlke
  • Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases
    Publication number: 20040077614
    Abstract: The invention relates to the use of esters of estriol, for example, an estriol 3,17-dipropionate or an estriol 3,17-dihexanoate, for the treatment of autoimmune diseases, such as multiple sclerosis (MS).
    Type: Application
    Filed: February 27, 2003
    Publication date: April 22, 2004
    Inventors: Walter Elger, Sybille Beier, Harald Von Keyserlingk, Frank Dahlke
  • Use of biogenic estriol sulfamate prodrugs for treatment of autoimmune diseases
    Publication number: 20040067923
    Abstract: The invention relates to the use of mono-sulfamate prodrugs of estriol, such as estriol-3-sulfamate, for the treatment of autoimmune diseases, such as multiple sclerosis (MS).
    Type: Application
    Filed: February 27, 2003
    Publication date: April 8, 2004
    Inventors: Walter Elger, Gudrun Reddersen, Birgitt Schneider, Harald Von Keyserlingk, Frank Dahlke, Sigfrid Schwarz